Paper1620171
Breast cancer (1)
Harris JR and 3 others. N Engl J Med, 1992. Cited by 571 papers, by iCite.
Cite this record
ConductScience Library. Breast cancer (1). Papers, record 1620171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1620171
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Female | |
| Humans | |
| Risk Factors | |
| United States |
Source PubMed
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 1435920 | Breast cancer. | https://conductscience.org/library/papers/1435920 | PubMed |
| Comment in | 1435921 | Breast cancer. | https://conductscience.org/library/papers/1435921 | PubMed |
| Comment in | 1435922 | Breast cancer. | https://conductscience.org/library/papers/1435922 | PubMed |
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 571 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42286049 | Bioinformatic pipeline to identify potential therapeutic targets with subsequent isolation and characterization of novel human anti- DDR1 antibodies. | Sci Rep | 2026 | https://conductscience.org/library/papers/42286049 | PubMed |
| 39525621 | Obesity and lack of breastfeeding: a perfect storm to augment risk of breast cancer? | Front Oncol | 2024 | https://conductscience.org/library/papers/39525621 | PubMed |
| 39420200 | Plasma C-peptide mammographic features and risk of breast cancer. | NPJ Breast Cancer | 2024 | https://conductscience.org/library/papers/39420200 | PubMed |
| 37581480 | Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb/c mice model of breast cancer. | J Cell Mol Med | 2023 | https://conductscience.org/library/papers/37581480 | PubMed |
| 37397537 | Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. | Genes Dis | 2023 | https://conductscience.org/library/papers/37397537 | PubMed |
| 37089493 | Breast cancer and occupation: Non-parametric and parametric net survival analyses among Swiss women (1990-2014). | Front Public Health | 2023 | https://conductscience.org/library/papers/37089493 | PubMed |
| 36648607 | LINC02381 suppresses cell proliferation and promotes apoptosis via attenuating IGF1R/PI3K/AKT signaling pathway in breast cancer. | Funct Integr Genomics | 2023 | https://conductscience.org/library/papers/36648607 | PubMed |
| 36511228 | Risk Factors Affecting Survival Time of Breast Cancer Patients: The case of Southwest Ethiopia. | J Res Health Sci | 2021 | https://conductscience.org/library/papers/36511228 | PubMed |
| 36232989 | An Insight into Molecular Targets of Breast Cancer Brain Metastasis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232989 | PubMed |
| 36077324 | Ligand-Specific Nano-Contrast Agents Promote Enhanced Breast Cancer CT Detection at 0.5 mg Au. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077324 | PubMed |
| 35633986 | A Motif-Based Network Analysis of Regulatory Patterns in Doxorubicin Effects on Treating Breast Cancer, a Systems Biology Study. | Avicenna J Med Biotechnol | 2022 | https://conductscience.org/library/papers/35633986 | PubMed |
| 35281604 | Detection of Breast Cancer Using Histopathological Image Classification Dataset with Deep Learning Techniques. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35281604 | PubMed |
| 35256855 | Artificial Intelligence-Based Breast Cancer Diagnosis Using Ultrasound Images and Grid-Based Deep Feature Generator. | Int J Gen Med | 2022 | https://conductscience.org/library/papers/35256855 | PubMed |
| 34683926 | The Impact of Improving Dermal Permeation on the Efficacy and Targeting of Liposome Nanoparticles as a Potential Treatment for Breast Cancer. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34683926 | PubMed |
| 34671674 | Development of Coriandrum sativum Oil Nanoemulgel and Evaluation of Its Antimicrobial and Anticancer Activity. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34671674 | PubMed |
| 34198930 | Why We Will Continue to Lose Our Battle with Cancers If We Do Not Stop Their Triggers from Environmental Pollution. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34198930 | PubMed |
| 33996216 | Photoacoustic dual-scan mammoscope: results from 38 patients. | Biomed Opt Express | 2021 | https://conductscience.org/library/papers/33996216 | PubMed |
| 33025024 | Breast cancer among Danish women occupationally exposed to diesel exhaust and polycyclic aromatic hydrocarbons, 1964-2016. | Scand J Work Environ Health | 2021 | https://conductscience.org/library/papers/33025024 | PubMed |
| 32816853 | Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice. | Cancer Res | 2020 | https://conductscience.org/library/papers/32816853 | PubMed |
| 32167569 | Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/32167569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1620171
GET https://conductscience.org/api/papers/v1/1620171/cited_by?page=2